VISN 5 MIRECC - General Publications 2010
About Us • Clinical • Education • Research
VISN 5 MIRECC home
Carpenter WT, Jr. Conceptualizing schizophrenia through attenuated symptoms in the population. Am J Psychiatry, 167(9):1013-1016, 2010. PMID:20826849
William R. Keller, Bernard A. Fischer, William T. Carpenter, Jr. Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going? CNS Neuroscience & Therapeutics (2):83-8, 2010
Slade E, Dixon L, Semmel S: Emergency Department Visits from 2001 to 2006: Trends in Visit Duration, Psychiatric Services 2010 Sep;61(9):878-84
Rosenberg S, Goldberg R, Dixon L, Wolford G, Slade E, Himelhoch S, Gallucci G, Potts W, Tapscott S, Welsh C: Assessing the STIRR Model of Best Practices for Blood‑Borne Infections in Clients with Severe Mental Illness, Psychiatric Services 2010 Sep;61(9):885-91.
Khaykin E, Ford DE, Pronovost PJ, Dixon L, Daumit GL. National Estimates of Adverse Events during Non-Psychiatric Hospitalizations for Persons with Schizophrenia. General Hospital Psychiatry, 2010 Jul-Aug;32(4):419-25.
Brown C, Leith J, Dickerson F, Medoff D, Kreyenbuhl J, Fang L, Goldberg, R., Potts, W., Dixon, L. (2010). Predictors of mortality in patients with serious mental illness and co-occurring type 2 diabetes. Psychiatry Research, 2010 177, 250-254.
Nossel I, Calmes C, Brown C, Kreyenbuhl J, Goldberg R, Fang L, Dixon L: Patterns of Emergency Room Use for Medical Conditions among those with Serious Mental Illness, Psychiatric Services, 2010 61, 1251-4.
Ascher-Svanum H, Zhu B, Faries DE, Salkever D, Slade EP, Peng X, Conley RR. The cost of relapse and the predictors of relapse in the treatment of schizophrenia, BMC Psychiatry, 10:2, 2010, doi: 10.1186/1471-244X-10-2
Brown, L.D., & Lucksted, A. (2010). Chapter 2 – Theoretical Foundations of Mental Health Self-Help. In L. D. Brown & S. Wituk (Eds.), Mental Health Self-Help: Consumer and Family Initiatives (pp. 19-38). New York: Springer.
Goldberg, R. and Resnick, S. (2010). US Department of Veteran Affairs (VA) Efforts to Promote Psychosocial Rehabilitation and Recovery. Psychiatry Rehabilitation Journal, 33(4): 255-258.
Forbes, CB, Blanchard, JJ, Bennett, M, Horan, W.P., Kring, A., & Gur, R. (2010). Initial development and preliminary validation of a new negative symptom measure: The Clinical Assessment Interview for Negative Symptoms. Schizophrenia Research, 124, 36-42.
Weiner, E., Conley, R. R., Ball, M. P., Feldman, S., Gold, J. M., Kelly, D. L., Wonodi, I., McMahon, R. P., & Buchanan, R. W. (2010). Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. Neuropsychopharmacology, 35(11), 2274-83.
